Westside Investment Management Inc. Trims Stock Holdings in Harrow, Inc. (NASDAQ:HROW)

Westside Investment Management Inc. lowered its stake in Harrow, Inc. (NASDAQ:HROW - Free Report) by 21.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 165,944 shares of the company's stock after selling 44,000 shares during the quarter. Harrow makes up approximately 1.6% of Westside Investment Management Inc.'s investment portfolio, making the stock its 11th largest position. Westside Investment Management Inc. owned 0.47% of Harrow worth $7,451,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in HROW. Price T Rowe Associates Inc. MD boosted its position in Harrow by 6.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 16,672 shares of the company's stock worth $221,000 after buying an additional 1,033 shares during the period. Private Capital Management LLC lifted its holdings in shares of Harrow by 7.8% during the first quarter. Private Capital Management LLC now owns 3,012,393 shares of the company's stock worth $39,854,000 after purchasing an additional 217,896 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Harrow by 16.6% in the second quarter. Bank of New York Mellon Corp now owns 88,210 shares of the company's stock worth $1,843,000 after purchasing an additional 12,580 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Harrow by 2,730.7% in the second quarter. Allspring Global Investments Holdings LLC now owns 2,123 shares of the company's stock valued at $44,000 after purchasing an additional 2,048 shares during the period. Finally, nVerses Capital LLC bought a new position in Harrow during the 2nd quarter worth $33,000. Institutional investors own 72.76% of the company's stock.

Harrow Stock Down 3.3 %

HROW traded down $1.24 during mid-day trading on Thursday, reaching $36.50. 240,453 shares of the stock were exchanged, compared to its average volume of 505,108. Harrow, Inc. has a 1 year low of $9.13 and a 1 year high of $59.23. The company has a 50 day moving average price of $46.69 and a two-hundred day moving average price of $35.80. The stock has a market capitalization of $1.30 billion, a PE ratio of -40.15 and a beta of 0.69. The company has a debt-to-equity ratio of 3.23, a quick ratio of 1.44 and a current ratio of 1.55.

Wall Street Analysts Forecast Growth

HROW has been the subject of several recent research reports. Craig Hallum increased their price target on Harrow from $45.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, October 4th. Lake Street Capital increased their target price on shares of Harrow from $45.00 to $55.00 and gave the company a "buy" rating in a research report on Friday, October 4th. Finally, B. Riley dropped their price target on shares of Harrow from $73.00 to $69.00 and set a "buy" rating on the stock in a research report on Wednesday, December 4th.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.